AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal
AbbVie is planning to raise a minimum of $8 billion through an investment-grade bond offering to help finance its acquisition of Apogee Therapeutics. This debt financing demonstrates the company's confidence in the deal and its ability to secure capital markets funding for the substantial transaction.
1 Article
Trace's outlet lean is shown first — tap Left / Center / Right on each source to add your rating too.
- BloombergTrace: Center
AbbVie Seeks at Least $8 Billion in Debt to Fund Apogee Deal
AbbVie is planning to raise a minimum of $8 billion through an investment-grade bond offering to help finance its acquisition of Apogee Therapeutics. This debt financing demonstrates the company's confidence in the deal and its ability to secure capital markets funding for the substantial transaction.
Rate outletRead original
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending